Psoriasis Drug May Have Some Cardiometabolic Benefits

Nonrandomized trial shows 5%-6% reduction in both visceral and subcutaneous fat, but no effect on aortic vascular inflammation.
Medscape Medical News

source https://www.medscape.com/viewarticle/981484?src=rss